Fees and payments
We must take fees and charges to recover the cost of all activities that fall within the scope of the Therapeutic Goods Act 1989.
We are required to recover our costs for all activities that fall within the scope of the Therapeutic Goods Act 1989, including our public health responsibilities.
- A fee is charged for a service, such as a product evaluation.
- A charge is a form of tax on regulated industry and is applied annually based on a 1 July to 30 June financial year.
Each year we consult with industry representative bodies in relation to proposed changes to fees and charges and publish a Cost Recovery Implementation Statement (CRIS). The CRIS provides information on how we implement cost recovery activities associated with the registration and listing of medicines and inclusion of medical devices, including IVD devices, and biologicals onto the ARTG and the ongoing monitoring and surveillance of them.
-
-
-
Annual charges
Information about annual charges for product entries on the Australian Register of Therapeutic Goods (ARTG) and manufacturing licences. -
-
-
-
Forms (fees and payments)
The following forms are for the use of sponsors and manufacturers mainly regarding the payment of fees and charges. -
-
Annual Charge Exemption (ACE) scheme for therapeutic goods
The ACE scheme provides an exemption from annual charges until a product first generates a turnover.
Invoice and payment enquiries
| General Enquiries: accountsrec@health.gov.au Remittance Advices: TGARemittanceAdvices@health.gov.au | |
| Phone | 1800 020 653 (option 5)
|
| Postal address | TGA Revenue Management Regulatory Engagement Branch Therapeutic Goods Administration PO Box 100 Woden ACT 2606 Australia |
Latest articles
-
Sponsors and manufacturers reminded about upcoming financial deadlines
A reminder about financial deadlines that are approaching for sponsors and manufacturers.
Latest publications
-
This Cost Recovery Implementation Statement (CRIS) 2025-2026 provides information on how we implement, and cost recover our regulatory activities.
-
This Cost Recovery Implementation Statement (CRIS) 2024-2025 provides information on how we implement, and cost recover our regulatory activities.
-
This Cost Recovery Implementation Statement provides information on how the TGA, within the Department of Health, implements and cost recovers its regulatory activities.